Chief Medial Officer Trek Therapeutics
Infectious Disease
Robert G. Hindes works in the field of Infectious Disease. He attended Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School is ranked 74 in research and 67 in primary care medicine Robert Hindes is a published MD. He published 16 publications, including: 'Effects of clindamycin and gentamicin and other antimicrobial combinations against enterococci in an experimental model of intra-abdominal abscess.'
Publications
- Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.
- Randomized study of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 chronic hepatitis C.
- Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, mult...
- Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C.
- Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a rand...
- Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.
- Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation.
- Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a ...
- Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
- Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks.
- Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B.
- A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients.
- Agranulocytosis induced by abacavir.
- Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.
- Effects of clindamycin and gentamicin and other antimicrobial combinations against enterococci in an experimental model of intra-abdominal abscess.
Schools
Rutgers Medical School
Hospital Of The University Of Pennsylvania
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- First Health (Coventry Health Care) PPO
- Freedom Plan
- Oxford Liberty
Education
-
Beth Israel Deaconess Medical Center
-
Medical College of Pennsylvania and Hospital
-
Rutgers Robert Wood Johnson Medical School
Helpful Reviews
Give
Anonymous Review
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.
